ATC code None PubChem CID 22714308 Formula C18H14N4O3 Molar mass 334.329 g/mol | CAS Number 219846-31-8 ChemSpider 11584471 3D model (Jmol) Interactive image | |
 | ||
Radequinil (INN; AC-3933) is a cognitive enhancer which acts as a partial inverse agonist of the benzodiazepine site of the GABAA receptor. It was under development by Dainippon Sumitomo Pharma for the treatment of Alzheimer's disease and made it to phase II clinical trials but development seems to have been halted and it was never marketed.
References
Radequinil Wikipedia(Text) CC BY-SA